Chemoradiation for carcinoma of the cervix: Advances and opportunities

P. J. Eifel

Research output: Contribution to journalReview articlepeer-review

35 Scopus citations

Abstract

Although it is possible to cure many patients with locally advanced cervical cancer using radiation therapy alone, loco-regional relapse continues to be a component of most recurrences. To improve control rates, clinicians have investigated ways of combining chemotherapy and radiation for more than 30 years. Despite encouraging results from phase II trials of neoadjuvant chemotherapy, randomized trials failed to improve on the results with radiation therapy alone. For a number of reasons, early trials of concurrent chemoradiation were inconclusive. However, recent reports of five large prospective randomized trials demonstrated dramatic improvements in survival and local control rates when cisplatin-containing chemotherapy was given during radiation therapy. These results also suggest a number of avenues for future research. (C) 2000 by Radiation Research Society.

Original languageEnglish (US)
Pages (from-to)229-236
Number of pages8
JournalRadiation research
Volume154
Issue number3
DOIs
StatePublished - 2000

ASJC Scopus subject areas

  • Biophysics
  • Radiation
  • Radiology Nuclear Medicine and imaging

Fingerprint

Dive into the research topics of 'Chemoradiation for carcinoma of the cervix: Advances and opportunities'. Together they form a unique fingerprint.

Cite this